forest has well-established franchises in the therapeutic areas of the central nervous and cardiovascular systems, and we are always exploring new product opportunities that address a range of health conditions. our principal brands include bystolic® (nebivolol), daliresp™ (roflumilast), lexapro® (escitalopram oxalate), namenda® (memantine hcl), savella®(milnacipran hcl), teflaro™ (ceftaroline fosamil) for injection, and viibryd™ (vilazodone hcl). forest identifies, develops, and delivers pharmaceutical products that make a difference in people's lives.